From: Physical activity status prevents symptoms of long covid: Sulcovid-19 survey
Variable | Crude | Adjusted | ||
---|---|---|---|---|
Became inactive | Remained active | Became inactive | Remained active | |
Headache | 1.47 (1.13–1.91) | 0.59 (0.39–0.89) | 1.44 (1.02–2.03) | 0.26 (0.23–0.90) |
Dyspnea | 1.21 (0.86–1.72) | 0.42 (0.23–0.75) | 1.41 (0.87–2.30) | 0.71 (0.34–1.49) |
Dry cough | 0.99 (0.61–1.61) | 0.78 (0.44–1.36) | 0.80 (0.040-1.63) | 0.45 (0.16–1.27) |
Phlegm | 0.78 (0.33–1.85) | 0.14 (0.02–1.06) | 0.50 (0.11–2.13) | - |
Pain/discomfort breathing | 1.16 (0.73–1.82) | 0.50 (0.25-1.00) | 1.83 (1.01–2.32) | 0.58 (0.17–1.89) |
Ageusia | 1.33 (0.98–1.81) | 0.97 (0.68–1.40) | 1.19 (0.80–1.80) | 1.05 (0.65–1.68) |
Anosmia | 1.08 (0.80–1.47) | 1.09 (0.79–1.49) | 0.87 (0.57–1.32) | 1.11 (0.74–1.67) |
Sensitivity change | 1.34 (0.89–2.03) | 0.62 (0.34–1.13) | 1.46 (0.82–2.59) | 0.82 (0.35–1.93) |
Fatigue | 1.20 (0.97–1.49) | 0.44 (0.31–0.63) | 1.03 (0.77–1.40) | 0.63 (0.41–0.97) |
Sore throat | 1.72 (0.96–3.11) | 1.67 (0.90–3.10) | 1.80 (0.80–4.06) | 1.94 (0.81–4.65) |
Coryza | 1.06 (0.62–1.82) | 0.81 (0.43–1.53) | 1.03 (0.49–2.22) | 1.03 (0.43–2.48) |
Nasal congestion | 1.30 (0.76–2.22) | 0.94 (0.50–1.79) | 1.09 (0.51–2.35) | 1.11 (0.46–2.68) |
Nausea / vomiting | 1.75 (0.78–3.94) | 0.49 (0.11–2.08) | 1.68 (0.53–5.24) | 0.73 (0.92–5.73) |
Diarrhea | 1.03 (0.43–2.50) | 0.38 (0.09–1.62) | 1.34 (0.44–4.10) | - |
Arthralgia | 1.04 (0.75–1.45) | 0.51 (0.32–0.82) | 1.35 (0.88–2.08) | 0.94 (0.52–1.68) |
Myalgia | 1.07 (0.78–1.46) | 0.49 (0.31–0.78) | 1.23 (0.82–1.84) | 0.77 (0.43–1.38) |
Memory loss | 0.99 (0.78–1.26) | 0.62 (0.46–0.85) | 0.92 (0.65–1.28) | 0.72 (0.47–1.09) |
Attention loss | 1.08 (0.83–1.41) | 0.69 (0.49–0.96) | 1.16 (0.82–1.65) | 0.85 (0.55–1.33) |
Alteration Skin | 2.18 (1.34–3.54) | 0.71 (0.32–1.57) | 1.95 (0.99–3.80) | 0.90 (0.31–2.57) |
Long covid | 1.04 (0.90–1.21) | 0.73 (0.61–0.88) | 0.97 (0.80–1.17) | 0.80 (0.63–0.99) |